Zajac P - Search Results

1

Contemporary immunotherapy of solid tumors: from tumor-associated antigens to combination treatments.

Spagnoli GC, Ebrahimi M, Iezzi G, Mengus C, Zajac P. Spagnoli GC, et al. Among authors: zajac p. Curr Opin Drug Discov Devel. 2010 Mar;13(2):184-92. Curr Opin Drug Discov Devel. 2010. PMID: 20205052 Review.

2

MAGE-A Antigens and Cancer Immunotherapy.

Zajac P, Schultz-Thater E, Tornillo L, Sadowski C, Trella E, Mengus C, Iezzi G, Spagnoli GC. Zajac P, et al. Front Med (Lausanne). 2017 Mar 8;4:18. doi: 10.3389/fmed.2017.00018. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28337438 Free PMC article.

3

CD40 ligand-expressing recombinant vaccinia virus promotes the generation of CD8(+) central memory T cells.

Trella E, Raafat N, Mengus C, Traunecker E, Governa V, Heidtmann S, Heberer M, Oertli D, Spagnoli GC, Zajac P. Trella E, et al. Among authors: zajac p. Eur J Immunol. 2016 Feb;46(2):420-31. doi: 10.1002/eji.201545554. Epub 2015 Dec 2. Eur J Immunol. 2016. PMID: 26561341

4

Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma.

Adamina M, Rosenthal R, Weber WP, Frey DM, Viehl CT, Bolli M, Huegli RW, Jacob AL, Heberer M, Oertli D, Marti W, Spagnoli GC, Zajac P. Adamina M, et al. Among authors: zajac p. Mol Ther. 2010 Mar;18(3):651-9. doi: 10.1038/mt.2009.275. Epub 2009 Nov 24. Mol Ther. 2010. PMID: 19935776 Free PMC article. Clinical Trial.

5

Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial.

Adamina M, Weber WP, Rosenthal R, Schumacher R, Zajac P, Guller U, Frey DM, Oertli D, Zuber M, Heberer M, Spagnoli GC. Adamina M, et al. Among authors: zajac p. Contemp Clin Trials. 2008 Mar;29(2):165-81. doi: 10.1016/j.cct.2007.07.002. Epub 2007 Jul 17. Contemp Clin Trials. 2008. PMID: 17707139 Clinical Trial.

6

Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy.

Adamina M, Schumacher R, Zajac P, Weber WP, Rosenthal R, Groeper C, Feder C, Zurbriggen R, Amacker M, Spagnoli GC, Oertli D, Heberer M. Adamina M, et al. Among authors: zajac p. J Liposome Res. 2006;16(3):195-204. doi: 10.1080/08982100600848546. J Liposome Res. 2006. PMID: 16952874

7

Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.

Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, Rosenthal R, Zerkowski HR, Heberer M, Spagnoli GC. Groeper C, et al. Among authors: zajac p. Int J Cancer. 2007 Jan 15;120(2):337-43. doi: 10.1002/ijc.22309. Int J Cancer. 2007. PMID: 17066423

8

Clinical applications of recombinant virus-based cancer immunotherapy.

Adamina M, Daetwiler S, Rosenthal R, Zajac P. Adamina M, et al. Among authors: zajac p. Expert Opin Biol Ther. 2005 Sep;5(9):1211-24. doi: 10.1517/14712598.5.9.1211. Expert Opin Biol Ther. 2005. PMID: 16120051 Review.

9

Virosomes as new carrier system for cancer vaccines.

Schwaninger R, Waelti E, Zajac P, Wetterwald A, Mueller D, Gimmi CD. Schwaninger R, et al. Among authors: zajac p. Cancer Immunol Immunother. 2004 Nov;53(11):1005-17. doi: 10.1007/s00262-004-0545-5. Epub 2004 Jun 5. Cancer Immunol Immunother. 2004. PMID: 15185010

10

Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.

von Holzen U, Adamina M, Bolli M, Weber WP, Zajac P, Groeper C, Reschner A, Feder C, Schumacher R, Marti W, Oertli D, Heberer M, Spagnoli GC. von Holzen U, et al. Among authors: zajac p. Int J Cancer. 2005 Jun 10;115(2):248-55. doi: 10.1002/ijc.20858. Int J Cancer. 2005. PMID: 15688403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results